{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:13:30Z","timestamp":1785597210465,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Military logistics scientific research program in 2020","award":["CLJ20J033"],"award-info":[{"award-number":["CLJ20J033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis is a complex chronic inflammatory skin disease. The aim of this study was to analyze potential risk genes and molecular mechanisms associated with psoriasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>GSE54456, GSE114286, and GSE121212 were collected from gene expression omnibus (GEO) database. Differentially expressed genes (DEGs) between psoriasis and controls were screened respectively in three datasets and common DEGs were obtained. The biological role of common DEGs were identified by enrichment analysis. Hub genes were identified using protein\u2013protein interaction (PPI) networks and their risk for psoriasis was evaluated through logistic regression analysis. Moreover, differentially methylated positions (DMPs) between psoriasis and controls were obtained in the GSE115797 dataset. Methylation markers were identified after comparison with the common genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 118 common DEGs were identified, which were mainly involved in keratinocyte differentiation and IL-17 signaling pathway. Through PPI network, we identified top 10 degrees as hub genes. Among them, high expression of CXCL9 and SPRR1B may be risk factors for psoriasis. In addition, we selected 10 methylation-modified genes with the higher area under receiver operating characteristic curve (AUC) value as methylation markers. Nomogram showed that TGM6 and S100A9 may be associated with an increased risk of psoriasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This suggests that immune and inflammatory responses are active in keratinocytes of psoriatic skin. CXCL9, SPRR1B, TGM6 and S100A9 may be potential targets for the diagnosis and treatment of psoriasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41065-021-00186-w","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T16:08:09Z","timestamp":1623859689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Network analysis of potential risk genes for psoriasis"],"prefix":"10.1186","volume":"158","author":[{"given":"Huilin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-6986","authenticated-orcid":false,"given":"Jiangwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"1","key":"186_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13555-018-0279-5","volume":"9","author":"BE Strober","year":"2019","unstructured":"Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, et al. Clinical goals and barriers to effective psoriasis care. Dermatol Ther. 2019;9(1):5\u201318.","journal-title":"Dermatol Ther"},{"issue":"9997","key":"186_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386(9997):983\u201394.","journal-title":"Lancet"},{"issue":"5","key":"186_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1684\/ejd.2012.1802","volume":"22","author":"X Ding","year":"2012","unstructured":"Ding X, Wang T, Shen Y, Wang X, Zhou C, Tian S, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. 2012;22(5):663\u20137.","journal-title":"Eur J Dermatol"},{"key":"186_CR4","first-page":"5823684","volume":"2018","author":"M Tampa","year":"2018","unstructured":"Tampa M, Sarbu MI, Mitran MI, Mitran CI, Matei C, Georgescu SR. The pathophysiological mechanisms and the quest for biomarkers in psoriasis, a stress-related skin disease. Dis Markers. 2018;2018:5823684.","journal-title":"Dis Markers"},{"issue":"10","key":"186_CR5","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/ijms20102558","volume":"20","author":"TH Huang","year":"2019","unstructured":"Huang TH, Lin CF, Alalaiwe A, Yang SC, Fang JY. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci. 2019;20(10):2558.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"186_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"186_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2013.03.013","volume":"62","author":"JB Golden","year":"2013","unstructured":"Golden JB, McCormick TS, Ward NL. IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities. Cytokine. 2013;62(2):195\u2013201.","journal-title":"Cytokine"},{"key":"186_CR8","first-page":"7","volume":"6","author":"N Ayala-Fontanez","year":"2016","unstructured":"Ayala-Fontanez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2016;6:7\u201332.","journal-title":"Psoriasis (Auckl)"},{"issue":"2","key":"186_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jaci.2015.01.033","volume":"136","author":"S Mashiko","year":"2015","unstructured":"Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol. 2015;136(2):351-9.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"186_CR10","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3390\/ijms18122684","volume":"18","author":"YR Woo","year":"2017","unstructured":"Woo YR, Cho DH, Park HJ. Molecular mechanisms and management of a cutaneous inflammatory disorder: psoriasis. Int J Mol Sci. 2017;18(12):2684.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"186_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","volume":"38","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11\u201327.","journal-title":"Semin Immunopathol"},{"issue":"3","key":"186_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/ada.2020.96243","volume":"37","author":"B Nedoszytko","year":"2020","unstructured":"Nedoszytko B, Szczerkowska-Dobosz A, Stawczyk-Macieja M, Owczarczyk-Saczonek A, Reich A, Bartosinska J, et al. Pathogenesis of psoriasis in the \u201comic\u201d era. Part II. Genetic, genomic and epigenetic changes in psoriasis. Postepy Dermatol Alergol. 2020;37(3):283\u201398.","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"186_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/epi-2016-0162","volume":"9","author":"DP Potaczek","year":"2017","unstructured":"Potaczek DP, Harb H, Michel S, Alhamwe BA, Renz H, Tost J. Epigenetics and allergy: from basic mechanisms to clinical applications. Epigenomics. 2017;9(4):539\u201371.","journal-title":"Epigenomics"},{"issue":"7","key":"186_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbagrm.2012.02.014","volume":"1819","author":"R Chatterjee","year":"2012","unstructured":"Chatterjee R, Vinson C. CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim Biophys Acta. 2012;1819(7):763\u201370.","journal-title":"Biochim Biophys Acta"},{"issue":"47","key":"186_CR15","doi-asserted-by":"publisher","first-page":"20311","DOI":"10.1073\/pnas.1008688107","volume":"107","author":"V Rishi","year":"2010","unstructured":"Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, et al. CpG methylation of half-CRE sequences creates C\/EBPalpha binding sites that activate some tissue-specific genes. Proc Natl Acad Sci USA. 2010;107(47):20311\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"186_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0022-2143(96)90008-6","volume":"128","author":"YI Kim","year":"1996","unstructured":"Kim YI, Logan JW, Mason JB, Roubenoff R. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J Lab Clin Med. 1996;128(2):165\u201372.","journal-title":"J Lab Clin Med"},{"issue":"2 Suppl 1","key":"186_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1590\/abd1806-4841.2019940211","volume":"94","author":"M Arnone","year":"2019","unstructured":"Arnone M, Takahashi MDF, Carvalho AVE, Bernardo WM, Bressan AL, Ramos AMC, et al. Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2 Suppl 1):76\u2013107.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"186_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12918-018-0671-x","volume":"13","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Jhamb D, Shu L, Arneson D, Rajpal DK, Yang X. Multi-omics integration reveals molecular networks and regulators of psoriasis. BMC Syst Biol. 2019;13(1):8.","journal-title":"BMC Syst Biol"},{"issue":"9","key":"186_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri1689","volume":"5","author":"AM Bowcock","year":"2005","unstructured":"Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol. 2005;5(9):699\u2013711.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"186_CR20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","volume":"21","author":"M Furue","year":"2020","unstructured":"Furue M, Furue K, Tsuji G, Nakahara T. Interleukin-17A and Keratinocytes in Psoriasis. Int J Mol Sci. 2020;21(4):1275.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"186_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018;201(6):1605\u201313.","journal-title":"J Immunol"},{"issue":"3","key":"186_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","volume":"144","author":"JG Krueger","year":"2019","unstructured":"Krueger JG, Wharton KA Jr, Schlitt T, Suprun M, Torene RI, Jiang X, et al. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis. J Allergy Clin Immunol. 2019;144(3):750\u201363.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"186_CR23","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/molecules24112157","volume":"24","author":"BY Yang","year":"2019","unstructured":"Yang BY, Cheng YG, Liu Y, Liu Y, Tan JY, Guan W, et al. Datura Metel L. Ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production through TLR7\/8-MyD88-NF-kappaB-NLRP3 inflammasome pathway. Molecules. 2019;24(11):2157.","journal-title":"Molecules"},{"key":"186_CR24","doi-asserted-by":"publisher","first-page":"22745","DOI":"10.1038\/srep22745","volume":"6","author":"MH Tervaniemi","year":"2016","unstructured":"Tervaniemi MH, Katayama S, Skoog T, Siitonen HA, Vuola J, Nuutila K, et al. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis. Sci Rep. 2016;6:22745.","journal-title":"Sci Rep"},{"issue":"9","key":"186_CR25","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/jid.2012.123","volume":"132","author":"C Buerger","year":"2012","unstructured":"Buerger C, Richter B, Woth K, Salgo R, Malisiewicz B, Diehl S, et al. Interleukin-1beta interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis. J Invest Dermatol. 2012;132(9):2206\u201314.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"186_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.clindermatol.2007.08.013","volume":"25","author":"C Albanesi","year":"2007","unstructured":"Albanesi C, De Pita O, Girolomoni G. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol. 2007;25(6):581\u20138.","journal-title":"Clin Dermatol"},{"issue":"6","key":"186_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.clindermatol.2007.08.011","volume":"25","author":"BJ Nickoloff","year":"2007","unstructured":"Nickoloff BJ, Xin H, Nestle FO, Qin JZ. The cytokine and chemokine network in psoriasis. Clin Dermatol. 2007;25(6):568\u201373.","journal-title":"Clin Dermatol"},{"key":"186_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/CCID.S227896","volume":"13","author":"B Aydin","year":"2020","unstructured":"Aydin B, Arga KY, Karadag AS. Omics-driven biomarkers of psoriasis: recent insights, current challenges, and future prospects. Clin Cosmet Investig Dermatol. 2020;13:611\u201325.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"186_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41065-020-00141-1","volume":"157","author":"Y Luo","year":"2020","unstructured":"Luo Y, Luo Y, Chang J, Xiao Z, Zhou B. Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis. Hereditas. 2020;157(1):30.","journal-title":"Hereditas"},{"issue":"9","key":"186_CR30","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.7150\/thno.31144","volume":"9","author":"M Xu","year":"2019","unstructured":"Xu M, Deng J, Xu K, Zhu T, Han L, Yan Y, et al. In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine. Theranostics. 2019;9(9):2475\u201388.","journal-title":"Theranostics"},{"key":"186_CR31","doi-asserted-by":"publisher","first-page":"8171373","DOI":"10.1155\/2019\/8171373","volume":"2019","author":"N Aizawa","year":"2019","unstructured":"Aizawa N, Ishiuji Y, Tominaga M, Sakata S, Takahashi N, Yanaba K, et al. Relationship between the degrees of itch and serum lipocalin-2 levels in patients with psoriasis. J Immunol Res. 2019;2019:8171373.","journal-title":"J Immunol Res"},{"key":"186_CR32","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3389\/fimmu.2019.01525","volume":"10","author":"AEA Surace","year":"2019","unstructured":"Surace AEA, Hedrich CM. The role of epigenetics in autoimmune\/inflammatory disease. Front Immunol. 2019;10:1525.","journal-title":"Front Immunol"},{"issue":"11","key":"186_CR33","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1210\/me.2008-0232","volume":"22","author":"KC Chang","year":"2008","unstructured":"Chang KC, Shen Q, Oh IG, Jelinsky SA, Jenkins SF, Wang W, et al. Liver X receptor is a therapeutic target for photoaging and chronological skin aging. Mol Endocrinol. 2008;22(11):2407\u201319.","journal-title":"Mol Endocrinol"},{"issue":"6","key":"186_CR34","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","volume":"39","author":"HB Schonthaler","year":"2013","unstructured":"Schonthaler HB, Guinea-Viniegra J, Wculek SK, Ruppen I, Ximenez-Embun P, Guio-Carrion A, et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 2013;39(6):1171\u201381.","journal-title":"Immunity"},{"issue":"4","key":"186_CR35","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jid.2018.10.021","volume":"139","author":"V Choudhary","year":"2019","unstructured":"Choudhary V, Uaratanawong R, Patel RR, Patel H, Bao W, Hartney B, et al. Phosphatidylglycerol inhibits toll-like receptor-mediated inflammation by danger-associated molecular patterns. J Invest Dermatol. 2019;139(4):868\u201377.","journal-title":"J Invest Dermatol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-021-00186-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-021-00186-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-021-00186-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T16:11:03Z","timestamp":1623859863000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-021-00186-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1186\/s41065-021-00186-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}